Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-01-02 Sale |
2024-01-03 5:30 pm |
Arcutis Biotherapeutics Inc. | ARQT | Burnett Patrick See Remarks |
1,325 | $3.5408 | $4,692 | 57,032 (Direct) |
View |
| 2023-05-31 Purchase |
2023-12-01 8:51 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks |
1,463 | $6.38 | $9,334 | 782,982 (Indirect Direct) |
View |
| 2023-11-21 Sale |
2023-11-21 5:47 pm |
Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remark |
1,850 | $1.979 | $3,661 | 46,634 (Direct) |
View |
| 2023-10-24 Purchase |
2023-10-26 4:09 pm |
Arcutis Biotherapeutics Inc. | ARQT | Frazier Life Sciences VIII L.P. FHM LIFE SCIENCES VIII L.P. FHM LIFE SCIENCES VIII L.L.C. Topper James N Heron Patrick J 10% Owner |
80,000 | $2.5 | $200,000 | 8,827,261 (Indirect Direct) |
View |
| 2023-08-21 Sale |
2023-08-22 12:24 pm |
Arcutis Biotherapeutics Inc. | ARQT | Burnett Patrick See Remarks |
1,605 | $7.0419 | $11,302 | 58,357 (Direct) |
View |
| 2023-05-31 Sale |
2023-06-02 8:31 pm |
Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remark |
1,830 | $7.8023 | $14,278 | 43,609 (Direct) |
View |
| 2023-04-17 Sale |
2023-04-18 7:00 pm |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
8,500 | $13.97 | $118,728 | 197,274 (Indirect Direct) |
View |
| 2023-04-06 Sale |
2023-04-10 4:13 pm |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
8,500 | $12.01 | $102,085 | 205,774 (Indirect Direct) |
View |
| 2023-03-06 Sale |
2023-03-08 4:29 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks |
2,435 | $15.26 | $37,167 | 584,671 (Indirect Direct) |
View |
| 2023-03-06 Sale |
2023-03-08 4:29 pm |
Arcutis Biotherapeutics Inc. | ARQT | Burrows Scott L Chief Financial Officer |
291 | $15.26 | $4,442 | 59,115 (Direct) |
View |
| 2023-03-06 Sale |
2023-03-08 4:28 pm |
Arcutis Biotherapeutics Inc. | ARQT | Burnett Patrick See Remarks |
851 | $15.26 | $12,989 | 59,962 (Direct) |
View |
| 2023-03-06 Sale |
2023-03-08 4:26 pm |
Arcutis Biotherapeutics Inc. | ARQT | Turney Patricia A. SVP, Operations |
831 | $15.26 | $12,684 | 62,862 (Direct) |
View |
| 2023-03-06 Sale |
2023-03-08 4:26 pm |
Arcutis Biotherapeutics Inc. | ARQT | OSBORNE DAVID W Chief Technical Officer |
690 | $15.26 | $10,532 | 268,854 (Direct) |
View |
| 2023-03-06 Sale |
2023-03-08 4:25 pm |
Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer |
831 | $15.26 | $12,684 | 63,429 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-02-13 Option Award |
2024-02-15 6:47 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Moore Matthew Richard SVP and Chief Business Officer |
68,232 | $0 | 149,488 (Direct) |
View |
| 2024-02-13 Option Award |
2024-02-15 6:36 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Burnett Patrick See Remarks |
189,050 | $0 | 274,082 (Direct) |
View |
| 2024-02-13 Option Award |
2024-02-15 6:32 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remark |
119,550 | $0 | 194,184 (Direct) |
View |
| 2024-02-13 Option Award |
2024-02-15 6:30 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks |
264,882 | $0 | 1,123,041 (Direct) |
View |
| 2024-02-13 Option Award |
2024-02-15 6:23 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer |
11,365 | $0 | 152,757 (Direct) |
View |
| 2024-01-12 Option Award |
2024-01-17 4:35 pm |
N/A 2034-01-12 |
Arcutis Biotherapeutics Inc. | ARQT | Burnett Patrick See Remarks |
304,000 | $0 | 361,032 (Direct) |
View |
| 2024-01-12 Option Award |
2024-01-17 4:34 pm |
N/A 2034-01-12 |
Arcutis Biotherapeutics Inc. | ARQT | Edwards Larry Todd Chief Commercial Officer |
204,000 | $0 | 264,000 (Direct) |
View |
| 2024-01-12 Option Award |
2024-01-17 4:32 pm |
N/A 2034-01-12 |
Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remark |
204,000 | $0 | 250,634 (Direct) |
View |
| 2024-01-12 Option Award |
2024-01-17 4:30 pm |
N/A 2034-01-12 |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks |
535,000 | $0 | 1,037,019 (Direct) |
View |
| 2024-01-12 Option Award |
2024-01-17 4:28 pm |
N/A 0034-01-12 |
Arcutis Biotherapeutics Inc. | ARQT | Moore Matthew Richard SVP and Chief Business Officer |
154,000 | $0 | 180,590 (Direct) |
View |
| 2023-12-20 Gift |
2023-12-22 5:24 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks |
6,563 | $0 | 526,432 (Direct) |
View |
| 2023-12-01 Exercise |
2023-12-01 8:51 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks |
59,525 | $0 | 782,982 (Direct) |
View |
| 2023-12-01 Exercise |
2023-12-01 8:51 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks |
59,525 | $1.6806 | 782,982 (Direct) |
View |
| 2023-11-18 Option Award |
2023-11-21 5:47 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remark |
4,875 | $0 | 46,634 (Direct) |
View |
| 2023-09-27 Option Award |
2023-10-03 9:45 pm |
N/A 2033-09-27 |
Arcutis Biotherapeutics Inc. | ARQT | Edwards Larry Todd Chief Commercial Officer |
300,000 | $0 | 300,000 (Direct) |
View |
| 2023-08-29 Option Award |
2023-09-12 07:39 am |
N/A 2031-01-18 |
Arcutis Biotherapeutics Inc. | ARQT | Moore Matthew Richard SVP and Chief Business Officer |
12,500 | $0 | 12,500 (Direct) |
View |
| 2023-08-31 Option Award |
2023-09-05 9:38 pm |
N/A 2033-08-31 |
Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer |
125,000 | $0 | 125,000 (Direct) |
View |
Ownership |
2023-09-05 9:36 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer |
0 | $0 | 253,738 (Indirect) |
View |
| 2023-05-27 Option Award |
2023-06-02 8:31 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remark |
4,875 | $0 | 43,609 (Direct) |
View |
| 2023-05-31 Option Award |
2023-06-02 8:31 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remark |
1,463 | $6.38 | 43,609 (Direct) |
View |
| 2023-05-31 Option Award |
2023-06-02 7:22 pm |
N/A 2033-05-31 |
Arcutis Biotherapeutics Inc. | ARQT | LIN SUE-JEAN Director |
16,595 | $0 | 21,207 (Direct) |
View |
| 2023-05-31 Option Award |
2023-06-02 7:16 pm |
N/A 2033-05-31 |
Arcutis Biotherapeutics Inc. | ARQT | Heron Patrick J Director 10% Owner |
16,595 | $0 | 20,907 (Direct) |
View |
| 2023-05-31 Option Award |
2023-06-02 7:13 pm |
N/A 2033-05-31 |
Arcutis Biotherapeutics Inc. | ARQT | CHAUDHURI BHASKAR Director |
16,595 | $0 | 912,279 (Direct) |
View |
| 2023-05-31 Option Award |
2023-06-02 7:10 pm |
N/A 2033-05-31 |
Arcutis Biotherapeutics Inc. | ARQT | Curran Terrie Director |
16,595 | $0 | 20,907 (Direct) |
View |
| 2023-05-31 Option Award |
2023-06-02 7:08 pm |
N/A 2033-05-31 |
Arcutis Biotherapeutics Inc. | ARQT | Gilbert Halley E Director |
16,595 | $0 | 20,907 (Direct) |
View |
| 2023-05-31 Option Award |
2023-06-02 7:02 pm |
N/A 2033-05-31 |
Arcutis Biotherapeutics Inc. | ARQT | Leonard Keith R Director |
16,595 | $0 | 22,657 (Direct) |
View |
| 2023-05-31 Option Award |
2023-06-02 6:59 pm |
N/A 2033-05-31 |
Arcutis Biotherapeutics Inc. | ARQT | Krishnamohan Neha Director |
16,595 | $0 | 17,827 (Direct) |
View |
| 2023-05-31 Option Award |
2023-06-02 6:54 pm |
N/A 2033-05-31 |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
16,595 | $0 | 207,411 (Direct) |
View |
| 2023-04-17 Exercise |
2023-04-18 7:00 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
8,500 | $0 | 197,274 (Direct) |
View |
| 2023-04-17 Exercise |
2023-04-18 7:00 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
8,500 | $1.6806 | 197,274 (Direct) |
View |
| 2023-04-06 Exercise |
2023-04-10 4:13 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
8,500 | $0 | 205,774 (Direct) |
View |
| 2023-04-06 Exercise |
2023-04-10 4:13 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
8,500 | $1.6806 | 205,774 (Direct) |
View |
| 2023-03-02 Option Award(A) |
2023-03-31 9:54 pm |
N/A 2033-03-02 |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks |
319,500 | $0 | 688,592 (Direct) |
View |
| 2023-03-02 Option Award |
2023-03-06 6:58 pm |
N/A 2033-03-02 |
Arcutis Biotherapeutics Inc. | ARQT | Burrows Scott L Chief Financial Officer |
76,800 | $0 | 115,206 (Direct) |
View |